Cancer Head Neck
12
2
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
80.0%
-6.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning
Genomic Testing and Resulting Medical Decisions
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
Optimization of MRI for Radiation Therapy
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds
PREoPerAtive pREhabilitation in Patients With Head and Neck Cancer or Liver Cancer (PREPARE)
Neuroinflammation in Chronic Systemic Symptoms (CSS)
Effect of the Use of Symbiotics in Patients With Colon Cancer